AI assistant
Instil Bio, Inc. — Director's Dealing 2022
Mar 17, 2022
33728_dirs_2022-03-17_551f623a-d8f8-47ba-8857-f8e22bf31e36.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Instil Bio, Inc. (TIL)
CIK: 0001789769
Period of Report: 2022-03-15
Reporting Person: McGaughy R Kent Jr (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-03-15 | Common Stock | J | 260323 | — | Disposed | 8218467 | Indirect |
Footnotes
F1: The securities are held by Ibisbill, LP (the "LP"). CPMG, Inc. is the general partner of the LP and has voting and investment control over the shares beneficially owned by the LP. The Reporting Person is the sole shareholder and managing director of CPMG, Inc. and may be deemed to share voting and investment power with respect to the shares beneficially owned by the LP. The Reporting Person disclaims beneficial ownership of the shares beneficially owned by LP except to the extent of any pecuniary interest therein.
F2: The LP distributed these shares to its partners on a pro rata basis, for no consideration.